[
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-1",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#definitiongeneral421664",
    "clean_content": "Definition / general\n\n* Malignant tumor that consists of both squamous cell carcinoma and ductal adenocarcinoma components ([Digestion 2005;72:104](16172546), [Cancer 2003;99:372](14681946), [Int J Pancreatol 1999;26:85](10597404), [Arch Surg 1999;134:599](10367867))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-2",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#essentialfeatures421665",
    "clean_content": "Essential features\n\n* Malignant tumor consisting of both squamous cell carcinoma and ductal adenocarcinoma components ([Digestion 2005;72:104](16172546), [Cancer 2003;99:372](14681946), [Int J Pancreatol 1999;26:85](10597404), [Arch Surg 1999;134:599](10367867))* Closely related to and admixed with [pancreatic ductal adenocarcinoma (PDAC)](https://www.pathologyoutlines.com/topic/pancreasductal.html); some require 30% squamous differentiation for the diagnosis of adenosquamous carcinoma* Cases with < 30% of squamous component also behave like adenosquamous carcinoma and can be acknowledged as PDAC with focal (< 30%) squamous differentiation* Metastatic tumor can be solely composed of the glandular component ([Mod Pathol 2001;14:443](11353055))* Often has necrotic and cystic components ([Arch Surg 1999;134:599](10367867))* Behaves even worse than ordinary PDAC"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-3",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#icdcoding421667",
    "clean_content": "ICD coding\n\n* ICD-O: [8560/3](https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf#page=76) - adenosquamous carcinoma"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-4",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#epidemiology421668",
    "clean_content": "Epidemiology\n\n* Accounts for about ~2% of exocrine pancreatic malignancies* M:F = 2:1* Mean age of 65 years ([Arch Surg 1999;134:599](10367867))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-5",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#sites421669",
    "clean_content": "Sites\n\n* Body and tail of the pancreas is more often affected than the head ([J Surg Res 2012;174:12](21816433))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-6",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#etiology421671",
    "clean_content": "Etiology\n\n* Ionizing radiation of the pancreas may predispose to the occurrence of adenosquamous carcinoma ([Mod Pathol 2001;14:443](11353055))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-7",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#diagnosis421674",
    "clean_content": "Diagnosis\n\n* Generally discovered with radiology and confirmed on fine needle aspiration biopsy (FNAB) or resection"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-8",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#radiologydescription421676",
    "clean_content": "Radiology description\n\n* Similar to [pancreatic ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html) but many cases present with more round, lobulated lesion with extensive central necrosis* Portal venous system may contain tumor thrombus ([Abdom Radiol (NY) 2016;41:508](27039322))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-9",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#radiologyimages421677",
    "clean_content": "Radiology images\n\nContributed by Orhun Çığ Taşkın, M.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin03new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin03new.jpg)\n\nCystic and necrotic changes"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-10",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#prognosticfactors421678",
    "clean_content": "Prognostic factors\n\n* Similar to PDAC, stage is the most important prognostic factor"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-11",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#casereports421679",
    "clean_content": "Case reports\n\n* 63 year old man and 69 year old woman with adenosquamous carcinoma of the pancreas ([Annu Rev Pathol 2020;15:97](36309754))* 66 year old woman with adenosquamous carcinoma of the pancreas ([Clin Case Rep 2022;10:e6181](35937009))* 80 year old Japanese woman with adenosquamous carcinoma coexisting with intraductal papillary mucinous neoplasm of the pancreas ([J Med Case Rep 2023;17:72](36859393))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-12",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#treatment421680",
    "clean_content": "Treatment\n\n* Similar to [pancreatic ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html)* If the tumor is operable, complete surgical resection, followed by adjuvant chemotherapy; increasingly neoadjuvant therapy is utilized just as in PDAC ([Hum Pathol 2010;41:113](19801164),\n    [J Gastrointest Oncol 2015;6:115](25830031))* Even more aggressive than ordinary PDAC with a median survival of < 1 year ([Gastrointest Cancer Res 2013;6:75](23936547))* Based on the immunohistochemical results, 11% of patients are assumed to be potential candidates for therapy with antibodies against PD-1 / PDL1 ([Pancreatology 2021;21:920](33773917))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-13",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#grossdescription421682",
    "clean_content": "Gross description\n\n* Large, firm mass of the pancreas, with ill defined borders, often with necrotic component, with or without cystic areas* Some cases are more demarcated* Reference: [World J Gastrointest Oncol 2015;7:132](26380056)"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-14",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#microscopichistologicdescription421686",
    "clean_content": "Microscopic (histologic) description\n\n* Adenocarcinoma component can bare all the characteristics of classic [pancreatic ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html)* Squamous component can show keratinization with intercellular bridges or sheets of squamous cells with keratohyaline granules or pearls\n    + Some are adenoacanthoma-like, with bland mature squamous elements, whereas others are more basal-like (with high N:C ratio and basophilic appearance)* Adenocarcinoma and squamous components can vary greatly in the amount and distribution* Sarcomatous component can also be encountered ([Anticancer Res 2019;39:4575](31366562))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-15",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#microscopichistologicimages421687",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Orhun Çığ Taşkın, M.D., Raul S. Gonzalez, M.D. and AFIP  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin08anew.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin08anew.jpg)\n \n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin07new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin07new.jpg)\n \n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousgonzalez01new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousgonzalez01new.jpg)\n\nGlandular and squamous components\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin08bnew.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin08bnew.jpg)\n\np63\n\n  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP1new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP1new.jpg)\n\nAdenocarcinoma and squamous carcinoma\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP2new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP2new.jpg)\n\nSquamous components\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP3new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP3new.jpg)\n\nMucoepidermoid pattern\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP4anew.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP4anew.jpg)\n\nCAM5.2\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP4bnew.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamousAFIP4bnew.jpg)\n\nCK13"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-16",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#cytologydescription421689",
    "clean_content": "Cytology description\n\n* Squamous component may be undersampled but malignant squamous cells are highly significant for the diagnosis ([Acta Cytol 2013;57:139](23406837))* Glandular and squamous components can both be distinguished* Dense globules, silhouettes of squamous cells, anucleate squames, atypical cytoplasm and enlarged pyknotic nuclei are present in the prominent necrotic background* Sheets and clusters of atypical cells with nuclei of variable sizes and shapes ([Cancer 2003;99:372](14681946))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-17",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#cytologyimages421690",
    "clean_content": "Cytology images\n\nContributed by Orhun Çığ Taşkın, M.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin04new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin04new.jpg)\n\nPap stain\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin05new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin05new.jpg)\n\nCell block\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin06new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasadenosquamoustaskin06new.jpg)\n\nCell block, p40"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-18",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#positivestains421693",
    "clean_content": "Positive stains\n\n* Immunoreactivity for [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html) is identified* [p63](https://www.pathologyoutlines.com/topic/stainsp63.html),\n    [p40](https://www.pathologyoutlines.com/topic/stainsdeltaNp63.html),\n    [high molecular weight cytokeratin](https://www.pathologyoutlines.com/topic/stainsck34be12.html) specifically highlights the squamous component ([Mod Pathol 2005;18:1193](15976814), [Mod Pathol 2009;22:651](19270646))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-19",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#negativestains421694",
    "clean_content": "Negative stains\n\n* Loss of [SMAD4 / DPC4](https://www.pathologyoutlines.com/topic/stainsdpc4.html) protein expression"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-20",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#molecularcytogeneticsdescription421697",
    "clean_content": "Molecular / cytogenetics description\n\n* [*KRAS*](https://www.pathologyoutlines.com/topic/molecularKRAS.html) mutations occur in almost all cases ([Mod Pathol 2001;14:443](11353055), [Mod Pathol 2009;22:651](19270646))* *TP53* mutations and 3p loss are commonly encountered* Recently discovered basal-like molecular subtype of PDAC is believed to also represent adenosquamous carcinoma ([Nature 2016;531:47](26909576))* Both components are believed to originate from the same progenitor cell ([J Pathol 2017;243:155](28722109))* Susceptibility genes including *MAP3K1, PDE4DIP* and *BCR* are frequently mutated in the germlines of patients ([Cancer Biomark 2020;27:389](31958074))"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-21",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#samplepathologyreport421700",
    "clean_content": "Sample pathology report\n\n* Pancreas, resection:\n  + Adenosquamous carcinoma (see synoptic report)"
  },
  {
    "id": "adenosquamous-carcinoma_43438_1750166972.txt-22",
    "source_document": "adenosquamous-carcinoma_43438_1750166972.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasadenosquamous.html#differentialdiagnosis421701",
    "clean_content": "Differential diagnosis\n\n* **Pure squamous cell carcinoma**:\n  + Extremely rare; most cases contain a small amount of glandular component, which is enough to call the tumor adenosquamous carcinoma* [Metastasis of adenosquamous carcinoma of the lung](https://www.pathologyoutlines.com/topic/lungtumoradenosquamous.html):\n    + Needs to be carefully excluded ([Virchows Arch 2004;444:527](15057558))"
  }
]